OnDemand: Addressing the Social and Behavioral Drivers of Prescribing

Cost: Free
Duration: One Hour

You may watch this as a live webinar taking place on September 1, 2022 from 1:00 pm to 2:15 pm ET, by clicking here to register.

Recording will be available  September 12, 2022.

Addressing the Social and Behavioral Drivers of Prescribing: Innovative Approaches to Antibiotic Stewardship 

Join NCQA for a discussion about the integration of social and behavioral science principles into antibiotic stewardship. Speakers will highlight the impact of social factors on antibiotic prescribing and share practical, evidence based, real-world strategies that address these factors. This session will highlight a novel antibiotic stewardship program to improve clinician communication practices to address patient expectations for antibiotics.   

Participants will learn the importance of considering the social and behavioral drivers of antibiotic prescribing in the design and implementation of improvement interventions. They will learn about evidence-based communication strategies clinicians can use to avoid inappropriate antibiotic prescribing and increase satisfaction with care.  Participants will be able to ask live questions about these topics.

 

Target Audience

 

  • Health care professionals 
  • Health care decision makers 
  • Consultants 
  • Health plans 
  • Health systems 
  • Health centers/health practices 
  • Hospitals 
  • Population health organizations 
  • Federal and state government agencies 

Learning Objectives

 

  • Describe the social and behavioral factors that influence antibiotic prescribing 
  • Understand the importance of using implementation strategies to promote the uptake of antibiotic stewardship across contexts 
  • Describe key communication strategies clinicians can use to decrease inappropriate antibiotic prescribing and increase satisfaction during visits for acute respiratory infections 
Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • 1.00 PCMH CCE
Course opens: 
03/18/2022
Course expires: 
09/01/2023
Rating: 
0

Rita Mangione-Smith, MD, MPH

Rita Mangione-Smith, MD, MPH, was appointed Vice President for Research and Health Care Innovation at Kaiser Permanente Washington and Executive Director of Kaiser Permanente Washington Health Research Institute (KPWHRI) in August 2019. She is also a Professor in the Department of Health Systems Science at Kaiser Permanente Bernard J. Tyson School of Medicine. Before joining Kaiser Permanente Washington, Dr. Mangione-Smith served as Professor and Chief of the Division of General Pediatrics and Hospital Medicine at the University of Washington Department of Pediatrics and as an Investigator in the Center for Child Health, Behavior, and Development at Seattle Children’s Research Institute.

As an NIH and AHRQ funded Senior Investigator at KPWHRI, Dr. Mangione-Smith’s research primarily focuses on assessing pediatric quality of care and then developing, implementing, and rigorously evaluating quality improvement interventions in areas such as hospital-to-home care transitions, hospital-based mental health care, and inpatient care for respiratory illnesses. Over the past twenty years, she has also conducted extensive research on doctor-parent communication, studying how interactions influence the decision to prescribe antibiotics for acute respiratory tract illness in pediatric outpatient settings. Based on this work, she developed an evidence-based, multifaceted quality improvement intervention for outpatient providers called Dialogue Around Respiratory Illness treatment (DART). In a clinical trial conducted under funding from NICHD, the DART program was found to be highly effective in preventing inappropriate antibiotic prescribing for acute respiratory tract illnesses. This effective QI program has been broadly adopted on a national scale.

In 2018, AcademyHealth honored Dr. Mangione-Smith with its “Child Health Interest Group Lifetime Achievement Award,” recognizing her significant and lasting contributions to child health services research. She also received the 2017 Academic Pediatric Association Research Award, the organization’s highest award for research excellence and achievement.

 

Julia E. Szymczak, PhD

Julia Szymczak is an Assistant Professor of Epidemiology and Medicine (Infectious Diseases) at the University of Pennsylvania’s Perelman School of Medicine. Dr. Szymczak is a medical sociologist with expertise in the social and cultural determinants of decision-making and behavior in healthcare organizations. She is an internationally recognized expert on the sociobehavioral dynamics that shape antimicrobial use across clinical contexts in human and veterinary medicine and in the application of implementation science frameworks to research in antimicrobial stewardship. Her research on antimicrobials and stewardship has been funded by AHRQ, CDC and PCORI and her peer-reviewed scholarship has appeared in high impact clinical and social science journals. She is the recipient of the 2020 SHEA Research Scholar Award and a newly appointed Voting Member on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). In addition to her research, Dr. Szymczak serves as the Associate Director for Social Science Methods in Healthcare Delivery Science at The Children's Hospital of Philadelphia (CHOP) and is an Associate Editor of BMJ Quality and Safety. She is also an award-winning teacher and mentor, who strives to train clinical scholars in social science theory-informed methodology to improve the delivery of healthcare. She completed a Postdoctoral Fellowship in the Division of Infectious Diseases at CHOP, holds Ph.D. and M.A. degrees in sociology from the University of Pennsylvania and a B.A. in sociology, summa cum laude, from Brandeis University.

imageIn support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team. 

This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™. 

This educational activity is approved for 1.0 nursing contact hours.*

The assigned universal program number: JA0004597-0000-22-032-H04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.

This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.  

* Please note – You must attend the entire program to be eligible for total number of contact hours.

NABP Credit Reporting 

If you are a pharmacist completing a course offering CPE credits, please notify NCQA through ncqa.org within 14 calendar days that you have completed a CPE course. You must provide the title of the course, your NABP identification number and your DOB (month/date) within the notification to NCQA. We also recommend you update your education.ncqa.org profile with your NABP identification number.  

Disclosure of Relevant Financial Relationships

The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.

For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution.  For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist with the following companies/organizations:

Faculty:
Rita Mangione-Smith : None
Julie Szymczak: None

Additional Planning Committee Members:
Cathy Beckner: None
Nancy McGee: None
Sepheen Byron: Dr. Byron received funding from the Centers for Disease Control and Prevention (contract no. 75D30120C08243) to develop the measure related to antibiotic utilization.

This program was developed in part by NCQA staff.

Acknowledgement
Support for this project was provided by The Pew Charitable Trusts.

Disclaimer
“The views expressed are those of the author(s) and do not necessarily reflect the views of The Pew Charitable Trusts”.

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • 1.00 PCMH CCE
Please login or register to take this course.